Damon Sutherland
Senior Vice-President
CI Assante Private Client
As Senior Vice-President, Sales & Wealth Services at CI Assante Private Client and Stonegate Private Counsel, Damon leads and coordinates the firm’s multi-disciplined sales and wealth planning professionals who provide support to Assante and Stonegate advisors and their clients. His focus is on the effective delivery of our practice-oriented service teams that work alongside advisors to enhance their service offering and help deliver a truly comprehensive client experience. Damon has 17 years of investment industry experience. He joined Assante in 2003 and transitioned to a sales role at CI Investments in 2005. From 2008 to 2017, Damon was Vice-President of Sales at CI, working with Assante advisors to help them grow and enhance their businesses. Damon holds an Honours Bachelor of Commerce degree from the University of Guelph.
Drummond Brodeur
Senior Vice-President and Global Strategist
CI Global Asset Management
Drummond Brodeur is Senior Vice-President and Global Strategist at Signature Global Asset Management. Mr. Brodeur has been in the investment industry since 1989. He has a strong background focused on China and the Pacific Basin. Prior to joining Signature in 2007, he oversaw international portfolios as vice-president of investments at KBSH Capital Management Ltd., as a senior analyst of Asian equities with Caisse de dépôt et placement du Québec, and as a portfolio manager of Asian equities at Bankers Trust Australia. Mr. Brodeur holds a Bachelor of Arts from the University of Western Ontario, a Master of Arts and Master of Business Administration from Monash University in Melbourne, Australia, and the Chartered Financial Analyst designation.
Jeff Elliott PHD, CFA
Vice-President, Portfolio Management and Portfolio Manager
CI Global Asset Management
Jeff Elliott, Vice-President, Portfolio Management and Portfolio Manager, specializes in the global healthcare sector. He has over 16 years of investment industry experience. Prior to joining Signature in 2013, Dr. Elliott analyzed global pharmaceutical equities at Sectoral Asset Management and was a senior equity research analyst at UBS Securities in New York and Toronto. Dr. Elliott holds a B.Sc. in Biochemistry from Queen’s University, a Ph.D. in Molecular Biology and Biochemistry from Simon Fraser University, an MBA from the University of Western Ontario and holds the Chartered Financial Analyst designation.